APOTEX-Amisulpride 400 mg tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

amisulpride, Quantity: 400 mg

Saadav alates:

GM Pharma International Pty Ltd

INN (Rahvusvaheline Nimetus):

Amisulpride

Ravimvorm:

Tablet, film coated

Koostis:

Excipient Ingredients: titanium dioxide; sodium starch glycollate type A; methylcellulose; magnesium stearate; macrogol 6000; microcrystalline cellulose; lactose monohydrate; purified talc; basic butylated methacrylate copolymer

Manustamisviis:

Oral

Ühikuid pakis:

100, 50, 60, 10, 90

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Toote kokkuvõte:

Visual Identification: White to off-white, 18 x 8mm capsule shaped, film-coated tablets with breakline on one side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2011-11-03